KVUE:NYSE
Kenvue Inc
$18.91
arrow_upward
+1.29%(+0.24) 1D
$18.85
arrow_downward
-0.32% (-0.060)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 16, 4:00:05 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa KVUE...
Buksan
$18.74
Mataas
$18.94
Mababa
$18.72
Mkt. cap
36.32B
Avg. na dami
24.62M
Dami
27.69M
Dividend
4.44%
Bawat tatlong buwang dividend
$0.21
Petsa ng ex-dividend
Set 21, 2026
P/E ratio
21.92
Mataas nang 52-wk
$20.13
Mababa nang 52-wk
$14.02
EPS
$0.86
Beta
0.48
Mga natitirang share
1.92B
Bilang ng mga empleyado
22K
Buksan
$18.74
Mataas
$18.94
Mababa
$18.72
Mkt. cap
36.32B
Avg. na dami
24.62M
Dami
27.69M
Dividend
4.44%
Bawat tatlong buwang dividend
$0.21
Petsa ng ex-dividend
Set 21, 2026
P/E ratio
21.92
Mataas nang 52-wk
$20.13
Mababa nang 52-wk
$14.02
EPS
$0.86
Beta
0.48
Mga natitirang share
1.92B
Bilang ng mga empleyado
22K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
CNBC
·
9 oras ang nakalipas
Kimberly-Clark is having its best week in four years. Here's what is propelling shares higher
Stock Traders Daily
·
1 araw ang nakalipas
(KVUE) as a Liquidity Pulse for Institutional Tactics
News Corp
·
1 araw ang nakalipas
Kenvue Inc. stock rises Thursday, outperforms market
Yahoo Finance
·
1 araw ang nakalipas
What to Expect From Kenvue's Next Quarterly Earnings Report
Profile
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Tungkol sa Kenvue Inc
CEOKirk Perry
Mga Empleyado21.9K
Itinatag2022
HeadquartersSummit, New Jersey, Estados Unidos
SektorPersonal care products
Websitekenvue.com